T. Rowe Price Associates’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $111K | Buy |
|
|||||
|
2025
Q3 | $75K | Buy |
|
|||||
|
2025
Q2 | $62K | Buy |
|
|||||
|
2025
Q1 | $36K | Buy |
|
|||||
|
2024
Q4 | $60K | Buy |
|
|||||
|
2024
Q3 | $89K | Hold |
|
|||||
|
2024
Q2 | $98K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $56K | Sell |
|
|||||
|
2019
Q1 | $130K | Sell |
|
|||||
|
2018
Q4 | $4.31M | Sell |
|
|||||
|
2018
Q3 | $14.5M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $226K | Sell |
|
|||||
|
2016
Q3 | $235K | Hold |
|
|||||
|
2016
Q2 | $426K | Sell |
|
|||||
|
2016
Q1 | $550K | Sell |
|
|||||
|
2015
Q4 | $669K | Sell |
|
|||||
|
2015
Q3 | $14.3M | Sell |
|
|||||
|
2015
Q2 | $17.7M | Sell |
|
|||||
|
2015
Q1 | $21.1M | Buy |
|